# EXPAREL

NDC: 65250-133
Generic name: bupivacaine
Labeler / Manufacturer: Pacira Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION, LIPOSOMAL
Routes: INFILTRATION
Marketing started: 20160101

FDA application: NDA022496

## Active ingredients

- BUPIVACAINE: 13.3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65250-133"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65250-133
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb5a9e59-0f51-11df-8a39-0800200c9a66